What’s new

• Rajasthan PPP project revenue guidance for FY27 slashed to ₹100-150 cr from ₹200-250 cr.
• Rollout of 27 mother labs and 800 collection centers delayed to Q2 FY27.
• Days sales outstanding stuck at 139 days, above the 120-day target.

Why it matters

The guidance cut halves the expected FY27 contribution from a project central to Krsnaa's public-sector growth story. It lands just as the company reports its first-ever ₹1,000 crore net profit year.

What we’re watching

• Whether the delayed Q2 FY27 Rajasthan rollout proceeds on the new schedule.
• Progress toward the retail diagnostics break-even target for FY27.
• Movement in DSO toward the 120-day target, a critical cash-flow metric.

The full read

Krsnaa just logged its first ₹1,000 crore profit year. It also cut in half the revenue outlook for the project meant to fund the next phase. The Rajasthan PPP project now targets ₹100-150 crore for FY27, down from a ₹200-250 crore aspiration. The reason is a six-month delay in rolling out 27 mother labs and 800 collection centers. That rollout was supposed to be complete by Q4 FY26. Now it's a Q2 FY27 event. Meanwhile, the company is deploying a ₹500 crore capex plan and retail diagnostics grew sixfold to ₹60 crore. But 139 days of receivables remain stuck above the 120-day target. Management speaks of a ₹6,000-7,000 crore opportunity over five to seven years. The immediate problem is simpler. The FY27 bridge to that future just got cut in width.

Primary source: BSE · NSE

What’s new

• Krsnaa Diagnostics released management commentary following its Q4 and FY26 audited results.
• The update details growth in the company's retail vertical.
• Management reports improvements in operating cash flow.

Why it matters

This release is a standard post-results communication that adds qualitative context to numbers already processed. It contains no new financial surprises or material data points.

What we’re watching

• Sustained growth in the retail diagnostic vertical.
• Further improvements in operating cash flow metrics.
• Any future updates on diagnostic center expansion.

The full read

Krsnaa Diagnostics has released management commentary to accompany its previously disclosed audited results for Q4 and FY26.

Routine.

The update provides qualitative context regarding the company's retail vertical growth and improvements in operating cash flow. Because the financial figures were already public, this release introduces no new material data or surprises for investors to consider.

Primary source: BSE · NSE

What’s new

• Krsnaa Diagnostics released its audited FY26 standalone and consolidated results.
• Consolidated profit of ₹101.4 cr matches previously disclosed figures.
• The filing includes a previously communicated emphasis of matter regarding a tax demand.

Why it matters

This is a routine filing that confirms earlier guidance. Investors should treat these results as a formalization of known data rather than a new event.

What we’re watching

• Updates on the tax demand mentioned in the emphasis of matter.
• Future revenue growth trends beyond the current modest levels.
• Any shift in operational margins in upcoming quarterly reports.

The full read

Krsnaa Diagnostics has released its audited results for FY26, confirming a consolidated profit of ₹101.4 crore and a standalone profit of ₹102.7 crore. These figures were already known to the market, as was the modest revenue growth and the one-time fair value gain. No surprises here. The filing also reiterates a tax demand previously flagged as an emphasis of matter. The company must still work through these outstanding regulatory hurdles while attempting to accelerate its revenue growth in the coming fiscal year.

Primary source: BSE · NSE

What’s new

• Audited FY26 standalone PAT is ₹102.7 crore; consolidated PAT is ₹101.4 crore.
• A ₹62.7 crore tax demand carries an emphasis of matter in the auditors' report.
• Results show modest revenue growth and a 24% year-on-year PAT increase.

Why it matters

This is a routine compliance filing. The profit figures were already public. The only unresolved material item is the ₹62.7 crore tax demand, which remains a contingent liability. For investors, the filing changes nothing about the company's trajectory or the risk on its balance sheet.

What we’re watching

• Progress on the ₹62.7 crore tax demand.
• Whether the associate fair-valuation gain recurs in future years.
• Next quarter's revenue trajectory to gauge the 'modest growth' pace.

The full read

Krsnaa Diagnostics' FY26 results are now formally audited. Standalone profit reached ₹102.7 crore, up 24% year-on-year. The consolidated figure is ₹101.4 crore. The numbers themselves are stale: they were released previously and the market has already absorbed them. The only live issue is the auditors' emphasis of matter on a ₹62.7 crore tax demand that the company still faces. A one-time gain from the fair valuation of an associate also boosted the bottom line. This is a compliance box-tick. It adds nothing to the investment thesis.

Primary source: BSE · NSE

What’s new

• Standalone profit rose 24% to ₹102.7 crore, but ₹25.9 crore was a one-time gain.
• Auditors disclosed a ₹62.7 crore tax demand from a search assessment spanning seven years.
• Borrowings surged from ₹16.6 crore to ₹490.5 crore after a ₹417.4 crore NCD issuance.

Why it matters

The headline profit number is misleading. Strip out the one-off gain, and operating performance was flat, with revenue stuck at ₹690.9 crore. The ₹62.7 crore tax claim is nearly 60% of reported profit, creating a real financial overhang despite management's appeal.

What we’re watching

• Outcome of the tax appeal — the demand equals 61% of FY26 profit.
• How the ₹490.5 crore debt pile impacts future interest costs.
• Revenue growth in core diagnostics business after a flat year.

The full read

Krsnaa Diagnostics' 24% profit growth looks solid until you see what's inside. The ₹102.7 crore standalone net profit included a ₹25.9 crore one-time gain from revaluing an associate. Revenue was flat at ₹690.9 crore. The real number to watch isn't profit but the ₹62.7 crore tax demand from search assessments spanning seven years. That's 61% of reported profit, now under appeal. Meanwhile, the balance sheet has fundamentally changed. Total debt jumped from ₹16.6 crore to ₹490.5 crore after a ₹417.4 crore NCD issuance for expansion. The company is putting significant capital to work while fighting a tax claim that could wipe out two years of profit.

Primary source: BSE · NSE

What’s new

• Tax assessment orders totaling ₹11.3 cr for FY19 and FY20 after a 2022 search.
• Amount is a mere 0.6% of the ₹1,836 cr market cap.
• Company has challenged the orders; near-term cash outflow unlikely.

Why it matters

A tax demand this size is barely material for a company of Krsnaa's scale. Management's contest stance further reduces immediate risk. The delayed disclosure is a minor governance blemish but won't alter the business outlook.

What we’re watching

• Outcome of appellate proceedings.
• Any additional tax demands from the same search.
• Steps taken to improve disclosure compliance.

The full read

Krsnaa Diagnostics has received income tax assessment orders for ₹11.3 crore for assessment years 2018-19 and 2019-20, following a search conducted in July 2022. The demand represents just 0.6% of the company's ₹1,836 crore market cap, making it a non-material event. Management says it has challenged the orders and is confident of a favourable outcome, which lowers the probability of near-term cash outflow. A minor governance concern arises from the delayed disclosure due to internal oversight, but this does not change the fundamental investment case. This is a routine tax litigation update with limited immediate price impact.

Primary source: BSE · NSE